Yushun Wan

机构：Chongqing Medical University · ORCID：0000-0003-0496-6315

发表论文 50 篇 · 总被引 14366 次 · h-index 20

代表论文

• Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection (2021 · PLoS Pathogens · 被引 80)
• The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates (2021 · eLife · 被引 63)
• The Development of a Novel Nanobody Therapeutic for SARS-CoV-2 (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 25)
• A T cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies (2024 · JCI Insight · 被引 14)
• Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein (2023 · eLife · 被引 13)
• Clinical features of HAdV-55 in children with respiratory tract infections: a retrospective case series and literature review (2025 · BMC Infectious Diseases · 被引 6)